<DOC>
	<DOCNO>NCT02764645</DOCNO>
	<brief_summary>This single center , prospective study : The 'CardioGard Cannula ' Gaseous embolus capture result - show improvement control group .</brief_summary>
	<brief_title>Performance CARDIOGARD Cannula</brief_title>
	<detailed_description>Patients refer CPB procedure offer participate study . Patients ask sign inform consent form ( ICF ) , prior perform study related procedure . The point enrollment time patient sign date ICF . Following enrollment , patient undergo screen evaluation ( include Neurological assessment ) determine eligibility . Screening failure identify screen log . Patients find meet inclusion criterion none exclusion criterion compose evaluable cohort study . Screening failure subject count part target patient sample size include analysis . Patients randomized phase surgery CardioGard Cannula comparator cannulae remain blinded group assignment 30 day follow-up evaluation .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<criteria>1 . Patient indicate firsttime nonemergent procedure cardiopulmonary bypass expect last 6 hour . 2 . Patient undergoing elective isolate coronary artery bypass surgery ( CABG ) , elective isolated aortic/mitral valve replacement ( AVR/MVR ) elective combine aortic/mitral valve replacement ( AVR/MVR ) coronary artery bypass surgery ( CABG ) . 3 . The patient &gt; 50 &lt; 85 year age . 4 . The patient 's body weight compatible blood net flow 4 5 [ l/min ] . 5 . Patient leave ventricular ejection fraction &gt; 30 % assess either echocardiography , angiography radio nuclear assessment ( MUGA ) 6 . The patient willing participate evidence sign write informed consent . 7 . Male nonpregnant female patient ( Note : Females child bear potential must negative pregnancy test ) 1 . Patient abnormal clot mechanism : PT 60 % , PTT &gt; 2 normal . 2 . Patient aortic trauma . 3 . Patient contraindicate open heart surgery bypass machine . 4 . Patient undergoing redo procedure . 5 . Patient intend operation perform use minimally invasive surgical technique ( e.g. , ministernotomy ) 6 . Patient pathology affect his/her neurological condition . 7 . Patient emergency operation require . 8 . Patient know allergy Heparin 9 . Patient major comorbid condition ( ) could limit patient 's ability participate study , impact scientific integrity study , include limit : previous stroke critical preoperative state poor ventricular function severe pulmonary hypertension [ 19 ] Atheroembolism history cardiac failure [ 20 ] 10 . Current use drug might result high surgical risk significant postoperative complication . 11 . Psychological instability , inappropriate attitude motivation . 12 . Patients life threaten debilitate disease cardiac . 13 . Subjects currently enrol another investigational device drug trial complete primary end point clinically interfere current study endpoint .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Cardiopulmonary Bypass</keyword>
</DOC>